• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ CHROMAGAR¿ ORIENTATION AGAR (100 SHELF PACK); CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ CHROMAGAR¿ ORIENTATION AGAR (100 SHELF PACK); CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL Back to Search Results
Model Number 215081
Device Problem Contamination (1120)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/08/2022
Event Type  malfunction  
Event Description
It was reported that the plates were contaminated with bd bbl¿ chromagar¿ orientation agar (100 shelf pack).The following information was provided by the initial reporter: it was reported that the chromagar orientation plates are contaminated.
 
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the plates were contaminated with bd bbl¿ chromagar¿ orientation agar (100 shelf pack).The following information was provided by the initial reporter: it was reported that the chromagar orientation plates are contaminated.
 
Manufacturer Narrative
H.6 investigation summary: complaint investigation.During manufacturing of material 215081, media is formulated and sent through a high temperature short time sterilizer to remove bioburden.The petri dishes are subjected to uv radiation to decrease bioburden.The petri dishes are filled in a positive pressure hepa filtered environment.The filled plates are cooled and immediately wrapped into sleeves to decrease the introduction of microbes.Sleeves are then packaged into cartons and then transferred to a refrigerated truck (2 to 8 degrees c) for shipment to the distributor.Bd distributors are provided with the storage guidelines for the shipping and handling of bd media of 2 to 8 degrees c in a dark place.The batch history record for batch 1294578 was satisfactory and no quality notifications were generated during manufacturing and inspection of either batch.The release testing that is performed on this product does include physical attribute and bioburden testing.A sample of plates are incubated at 25 degrees c and at 35 degrees c for approximately 72 hours.All physical attribute and bioburden testing performed on this batch was satisfactory per bd internal procedures.Affected product does not have any sterility claims; the product is tested for bioburden prior to release to ensure that it conforms to product specifications.However, this does not ensure that the end-user will not receive a contaminated plate.The complaint history was reviewed, and complaints from other customers have been taken for batch 1294578 for agar defects but no other complaints have been taken for contamination.Retention samples from batch 1294578 were not available for inspection.Six photos were received for investigation.--three photos each show the bottom of a plate from batch 1294578 (time stamps 1252 and 1253) with an air bubble between the agar bed and plate bottom.--one photo shows the bottom of a plate from batch 1294578 (time stamp 1246) with a colony of growth.--one photo shows the bottom of a plate from batch 1294578 (time stamp 1252) with the agar bed fallen out of the plate bottom.--one photo shows the profile of a plate with the agar bed sitting in the plate lid rather than the plate bottom.No return samples were received for investigation.Air bubbles between the agar bed and plate bottom indicate agar bed fallout.Uneven agar was not observed in the photos.This complaint cannot be confirmed for uneven agar.This complaint can be confirmed for agar bed fallout and contamination.A trend was identified for contamination and investigation found opportunities for bioburden reduction in the manufacturing process.Additional trainings are planned with an ongoing training review for cleaning processes.Bd will continue to trend complaints for contamination and agar defects.Risk management file review assessed the potential risk for the defect as severity 1 per baltrmppmgenpuraph, rev 02, id 6.13.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ CHROMAGAR¿ ORIENTATION AGAR (100 SHELF PACK)
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key13359542
MDR Text Key288869251
Report Number1119779-2022-00122
Device Sequence Number1
Product Code JSH
UDI-Device Identifier10382902150814
UDI-Public10382902150814
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date02/15/2022
Device Model Number215081
Device Catalogue Number215081
Device Lot Number1294578
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-